We showed that doxorubicin-resistant 4T1 tumor cells upregulated the mRNA expression of COX2 and markedly enhanced PGE2 secretion; which suggest that simultaneous blockage of the PGE2 and COX2 loop may provide a potential target for the recruitment and differentiation of MDSCs35. This evidence concerns the gene PTGS2 and neoplasm.